117 related articles for article (PubMed ID: 37437745)
1. The effect of Apigenin on glycometabolism and cell death in an anaplastic thyroid cancer cell line.
Heydarzadeh S; Moshtaghie AA; Daneshpour M; Hedayati M
Toxicol Appl Pharmacol; 2023 Sep; 475():116626. PubMed ID: 37437745
[TBL] [Abstract][Full Text] [Related]
2. Regulation of iodine-glucose flip-flop in SW1736 anaplastic thyroid cancer cell line.
Heydarzadeh S; Moshtaghie AA; Daneshpour M; Hedayati M
J Endocrinol Invest; 2024 May; ():. PubMed ID: 38698299
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors.
Ciampi R; Vivaldi A; Romei C; Del Guerra A; Salvadori P; Cosci B; Pinchera A; Elisei R
Mol Cell Endocrinol; 2008 Sep; 291(1-2):57-62. PubMed ID: 18571834
[TBL] [Abstract][Full Text] [Related]
4. Expression of hypoxia-related glucose transporters GLUT1 and GLUT3 in benign, malignant and non-neoplastic thyroid lesions.
Jóźwiak P; Krześlak A; Pomorski L; Lipińska A
Mol Med Rep; 2012 Sep; 6(3):601-6. PubMed ID: 22752218
[TBL] [Abstract][Full Text] [Related]
5. Small interfering RNA (siRNA) against Slug induces apoptosis and sensitizes human anaplastic thyroid carcinoma cells to doxorubicin.
Pan Y; Liu P; Chen D; Dou L
Cancer Biomark; 2017; 18(4):357-366. PubMed ID: 28128736
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
[TBL] [Abstract][Full Text] [Related]
7. S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAFV600E/Mt to Vemurafenib.
Jiao X; Zhang H; Xu X; Yu Y; Zhang H; Zhang J; Ning L; Hao F; Liu X; Niu M; Chen CT; Chen D; Zhang K
Cell Physiol Biochem; 2018; 49(3):1143-1162. PubMed ID: 30196299
[TBL] [Abstract][Full Text] [Related]
8. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.
Krzeslak A; Wojcik-Krowiranda K; Forma E; Jozwiak P; Romanowicz H; Bienkiewicz A; Brys M
Pathol Oncol Res; 2012 Jul; 18(3):721-8. PubMed ID: 22270867
[TBL] [Abstract][Full Text] [Related]
9. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes.
Vaz CV; Marques R; Alves MG; Oliveira PF; Cavaco JE; Maia CJ; Socorro S
J Cancer Res Clin Oncol; 2016 Jan; 142(1):5-16. PubMed ID: 26048031
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced modulation of glucose transporter expression impacts
Xia H; Chen J; Gao H; Kong SN; Deivasigamani A; Shi M; Xie T; Hui KM
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):787-797. PubMed ID: 31832727
[TBL] [Abstract][Full Text] [Related]
11. Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells.
Melstrom LG; Salabat MR; Ding XZ; Milam BM; Strouch M; Pelling JC; Bentrem DJ
Pancreas; 2008 Nov; 37(4):426-31. PubMed ID: 18953257
[TBL] [Abstract][Full Text] [Related]
12. Suppression of AKT Potentiates Synergistic Cytotoxicity of Apigenin with TRAIL in Anaplastic Thyroid Carcinoma Cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Anticancer Res; 2015 Dec; 35(12):6529-37. PubMed ID: 26637867
[TBL] [Abstract][Full Text] [Related]
13. Effects of nutraceuticals on anaplastic thyroid cancer cells.
Allegri L; Rosignolo F; Mio C; Filetti S; Baldan F; Damante G
J Cancer Res Clin Oncol; 2018 Feb; 144(2):285-294. PubMed ID: 29197967
[TBL] [Abstract][Full Text] [Related]
14. Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts.
He L; Guo S; Zhu T; Chen C; Xu K
Med Sci Monit; 2020 Jun; 26():e922561. PubMed ID: 32594094
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of glucose transporters in human oral squamous cell carcinoma cells.
Paolini R; Moore C; Matthyssen T; Cirillo N; McCullough M; Farah CS; Botha H; Yap T; Celentano A
J Oral Pathol Med; 2022 Sep; 51(8):679-683. PubMed ID: 35920070
[TBL] [Abstract][Full Text] [Related]
16. Dynamic expression of glucose transporters 1 and 3 in the brain of diabetic rats with cerebral ischemia reperfusion.
Zhang WW; Zhang L; Hou WK; Xu YX; Xu H; Lou FC; Zhang Y; Wang Q
Chin Med J (Engl); 2009 Sep; 122(17):1996-2001. PubMed ID: 19781384
[TBL] [Abstract][Full Text] [Related]
17. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
[TBL] [Abstract][Full Text] [Related]
18. A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers.
Cohen SM; Mukerji R; Timmermann BN; Samadi AK; Cohen MS
Am J Surg; 2012 Dec; 204(6):895-900; discussion 900-1. PubMed ID: 23231932
[TBL] [Abstract][Full Text] [Related]
19. Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR-75.
Meneses AM; Medina RA; Kato S; Pinto M; Jaque MP; Lizama I; García Mde L; Nualart F; Owen GI
J Cell Physiol; 2008 Jan; 214(1):110-6. PubMed ID: 17559076
[TBL] [Abstract][Full Text] [Related]
20. Regulators of glucose uptake in thyroid cancer cell lines.
Heydarzadeh S; Moshtaghie AA; Daneshpoor M; Hedayati M
Cell Commun Signal; 2020 Jun; 18(1):83. PubMed ID: 32493394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
